{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:28:58Z","timestamp":1784291338163,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Inflammation plays a critical role in severe cerebral venous thrombosis (CVT) pathogenesis, but the benefits of anti-inflammatory therapies remain unclear. This study aimed to investigate the association between steroid therapy combined with anticoagulation and the prognosis of acute\/subacute severe CVT patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A prospective cohort study enrolled patients with acute\/subacute severe CVT at Xuanwu Hospital (July 2020\u2013January 2024). Patients were allocated into steroid and non-steroid groups based on the treatment they received. Functional outcomes (modified Rankin scale [mRS]) were evaluated at admission, discharge, and 6\u00a0months after discharge. Serum high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), cerebrospinal fluid (CSF) IL-6, and intracranial pressure were measured at admission and discharge in the steroid group. Fundoscopic Fris\u00e9n grades were assessed at admission and 6\u00a0months after discharge. Univariate and multivariate logistic regression were used to evaluat associations between steroid use and favorable outcomes (mRS \u22642) at the 6-month follow-up. Paired tests assessed changes in hs-CRP and other variables before and after treatment, and Spearman\u2019s correlations were used to analyze relationships between these changes and functional improvements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 107 and 58 patients in the steroid and non-steroid groups, respectively, were included in the analysis. Compared with the non-steroid group, the steroid group had a higher likelihood of achieving an mRS score of 0\u20132 (93.5% <jats:italic toggle=\"yes\">vs<\/jats:italic>. 82.5%, odds ratio [OR]\u00a0=\u00a02.98, <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.037) at the 6-month follow-up. After adjusting for confounding factors, the result remained consistent. Pulsed steroid therapy did not increase mortality during hospitalization or follow-up, nor did it lead to severe steroid-related complications (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&gt;0.05). Patients in the steroid group showed a significant reduction in serum hs-CRP, IL-6, CSF IL-6, and intracranial pressure at discharge compared to at admission, as well as a significant reduction in the fundoscopic Fris\u00e9n grade at the 6-month follow-up compare to at admission (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;0.001). A reduction in serum inflammatory marker levels during hospitalization positively correlated with improvements in functional outcomes (<jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0&lt;0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Short-term steroid use may be an effective and safe adjuvant therapy for acute\/subacute severe CVT when used alongside standard anticoagulant treatments, which are likely due to suppression of the inflammatory response. However, these findings require further validation in randomized controlled trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trail registration:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT05990894.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003502","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:00:15Z","timestamp":1741057215000},"page":"1825-1834","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Steroids combined with anticoagulant in acute\/subacute severe cerebral venous thrombosis"],"prefix":"10.1097","volume":"138","author":[{"given":"Shimin","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"},{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"},{"name":"Intracranial Hypertension & Cerebral Venous Disease Center, National Health Commission of China, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"},{"name":"Intracranial Hypertension & Cerebral Venous Disease Center, National Health Commission of China, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology & Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[{"name":"Intracranial Hypertension & Cerebral Venous Disease Center, National Health Commission of China, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"},{"name":"Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100069, China"},{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"},{"name":"Intracranial Hypertension & Cerebral Venous Disease Center, National Health Commission of China, Xuanwu Hospital, Capital Medical University, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.10.001","article-title":"Cerebral venous thrombosis: Analysis of a multicenter cohort from the United States","volume":"17","author":"Wasay","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jamaneurol.2020.1022","article-title":"Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: The TO-ACT randomized clinical trial","volume":"77","author":"Coutinho","year":"2020","journal-title":"JAMA Neurol"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12028-016-0256-8","article-title":"Severe cerebral venous and sinus thrombosis: Clinical course, imaging correlates, and prognosis","volume":"25","author":"Kowoll","year":"2016","journal-title":"Neurocrit Care"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/STROKEAHA.107.502658","article-title":"Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: A prospective study","volume":"39","author":"Stam","year":"2008","journal-title":"Stroke"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: A scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"873802","DOI":"10.3389\/fneur.2022.873802","article-title":"Inflammation and severe cerebral venous thrombosis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Neurol"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12974-022-02511-0","article-title":"Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis","volume":"19","author":"Ding","year":"2022","journal-title":"J Neuroinflammation"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"93","DOI":"10.14336\/AD.2020.0405","article-title":"Identifying biomarkers associated with venous infarction in acute\/subacute cerebral venous thrombosis","volume":"12","author":"Duan","year":"2021","journal-title":"Aging Dis"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/ene.14526","article-title":"Blood biomarkers associated with inflammation predict poor prognosis in cerebral venous thrombosis: A multicenter prospective observational study","volume":"28","author":"Aguiar de Sousa","year":"2021","journal-title":"Eur J Neurol"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"104856","DOI":"10.1016\/j.neuint.2020.104856","article-title":"Endoplasmic reticulum stress and oxidative stress contribute to neuronal pyroptosis caused by cerebral venous sinus thrombosis in rats: Involvement of TXNIP\/peroxynitrite-NLRP3 inflammasome activation","volume":"141","author":"Ding","year":"2020","journal-title":"Neurochem Int"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12974-018-1369-0","article-title":"Inflammation is correlated with severity and outcome of cerebral venous thrombosis","volume":"15","author":"Wang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2018.06.029","article-title":"Early BBB breakdown and subacute inflammasome activation and pyroptosis as a result of cerebral venous thrombosis","volume":"1699","author":"Rashad","year":"2018","journal-title":"Brain Res"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/STROKEAHA.109.562983","article-title":"Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis","volume":"41","author":"Nagai","year":"2010","journal-title":"Stroke"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/STROKEAHA.107.484089","article-title":"Are steroids useful to treat cerebral venous thrombosis?","volume":"39","author":"Canh\u00e3o","year":"2008","journal-title":"Stroke"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/svn-2020-000358","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: Executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis","volume":"5","author":"Fan","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis\u2013Endorsed by the European Academy of Neurology","volume":"24","author":"Ferro","year":"2017","journal-title":"Eur J Neurol"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"R19-20250805","first-page":"179","article-title":"Exploration of glucocorticoid combined with anticoagulation in acute\/subacute severe cerebral venous thrombosis (in Chinese)","volume":"44","author":"Hu","year":"2023","journal-title":"J Cap Med Univ"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.2147\/JIR.S428589","article-title":"An exploration of anti-inflammatory therapy in acute\/subacute severe cerebral venous thrombosis with hereditary protein C\/S deficiency: Case series","volume":"16","author":"Hao","year":"2023","journal-title":"J Inflamm Res"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/crad.2001.0880","article-title":"Magnetic resonance imaging of cerebral venous sinus thrombosis","volume":"57","author":"Connor","year":"2002","journal-title":"Clin Radiol"},{"key":"R23-20250805","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.STR.25.1.29","article-title":"Magnetic resonance imaging of thrombosed dural sinuses","volume":"25","author":"Isensee","year":"1994","journal-title":"Stroke"},{"key":"R24-20250805","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/STROKEAHA.115.011369","article-title":"Early detection and quantification of cerebral venous thrombosis by magnetic resonance black-blood thrombus imaging","volume":"47","author":"Yang","year":"2016","journal-title":"Stroke"},{"key":"R25-20250805","first-page":"1666","article-title":"Parenchymal abnormalities associated with cerebral venous sinus thrombosis: Assessment with diffusion-weighted MR imaging","volume":"25","author":"Mullins","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R26-20250805","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000079939","article-title":"Cerebral venous infarction: The pathophysiological concept","volume":"18","author":"Schaller","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"R27-20250805","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: A nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R28-20250805","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J Clin Gastroenterol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:05:06Z","timestamp":1754366706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003502","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"2024-08-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}